logo
  

BT Group : Openreach Announces Long-term FTTP Pricing

Openreach has announced a special offer for its wholesale Communications Provider customers which gives them long-term price certainty on its FTTP or Fibre-to-the-Premises technology, Telecom company BT Group plc (BT_A.L,BT) said in a statement.

Openreach is seeking to drive widespread adoption of ultrafast, ultra-reliable full fibre broadband.

BT noted that Openreach will give pricing certainty for up to 10 years in return for this 'stop-sell' commitment.

A single national rental price will apply to the entire Openreach FTTP footprint.

The offer will be open for participation between 1st October 2021 and 30th March 2022. The long-term pricing certainty will last until 30th September 2031 and be available across the entire FTTP footprint.

BT said it is investing 15 billion pounds to build the gigabit-capable technology to 25 million UK premises by December 2026 and it's making the technology available to 43k premises every week, with more than five million homes and businesses already able to place an order.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
RELATED NEWS
Follow RTT